{"nct_id":"NCT03084640","title":"Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma","status":"COMPLETED","status_verified_date":"2022-08","start_date":"2017-05-04","start_date_type":"ACTUAL","primary_completion_date":"2021-07-02","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}